COVID-Vaccination and Performance in Five Global Stock Market Indexes
Abstract
This paper analyses the response of stock markets to vaccine availability. Objective: the objective of this paper is to examine the differential effect of information about the arrival of COVID vaccine on the stock price performance of five main global stock market indexes. Prior work: the paper relies on the prior theory of Efficient Market Hypotheses (EMH). Method: data on stock price performance seven months before vaccine arrival and seven months within the vaccination period were from Trading Economics stock indexes archives for five main market indexes namely (Dow Jones, Shanghai, S&P, FTSE, and EURONEXT). The data were analysed using the t-test of mean difference in stock prices before and during vaccine at 5% alpha level. Findings: results for the five indexes analysis show that stock prices during the arrival of vaccine significantly outweigh the stock prices before vaccine arrival at p-values below 0.01, which are lower than the alpha value of 5%. The mean stock price increases during vaccine arrival ranges from 7% to over 20% for the different indexes. Implications: The paper provides practical information for investors who need to know how sensitive the various indexes are to vaccine information. The paper also provides an avenue for future research to expand on this initial research on vaccine effect on stock prices. Furthermore, the paper presents a veritable case study for economics and finance postgraduate students in the universities. Value: This paper fills existing gap in knowledge by being the first to analyse the effect of COVID vaccine arrival on the stock price of five main global stock indexes and contributes by indicating that stock indexes are sensitive to vaccine production with diverse percentages of sensitivity.
References
Baker, S. R., Bloom, N., Davis, S. J., Kost, K., Sammon, M., & Viratyosin, T. (2020). The unprecedented stock market reaction to COVID-19. The review of asset pricing studies, 10(4), 742-758.
Bansal, A. (2010). As You Sow, so Shall You Reap: Evidence of Innovation and Drug Portfolio Diversification from the Stock Market. Available at SSRN 1605127.
Basgoze, P., Yildiz, Y., & Metin Camgoz, S. (2016). Effect of brand value announcements on stock returns: empirical evidence from Turkey. Journal of Business Economics and management, 17(6), 1252-1269.
Beraldo, S., Montolio, D., & Turati, G. (2009). Healthy, educated and wealthy: A primer on the impact of public and private welfare expenditures on economic growth. The Journal of Socio-Economics, 38(6), 946-956.
Bloom, D. E., Canning, D., & Sevilla, J. P. (2001). The effect of health on economic growth: theory and evidence,https://www.nber.org/system/files/working_papers/w8587/w8587.pdf
Bloom, D., & Canning, D. (2003). Health as human capital and its impact on economic performance. The Geneva Papers on Risk and Insurance. Issues and Practice, 28(2), 304-315.
Bloom, David, and David Canning. "Health as human capital and its impact on economic performance." The Geneva Papers on Risk and Insurance. Issues and Practice 28.2 (2003): 304-315.
CMBC (2020) Hopes for a coronavirus vaccine are creating market winners — and losers,https://www.cnbc.com/2020/11/23/investing-coronavirus-vaccine-creates-market-winners-and-losers-.html
European Central Bank (2021) Rotation towards normality – the impact of COVID-19 vaccine-related news on global financial markets,https://www.ecb.europa.eu/pub/economic-bulletin/focus/2021/html/ecb.ebbox202101_02~f0960a5b38.en.html
Gao, X., Ren, Y., & Umar, M. (2021). To what extent does COVID-19 drive stock market volatility? A comparison between the US and China. Economic Research-Ekonomska Istraživanja, 1-21.
Hadian, M. O. H. A. M. M. A. D., Shojaee, S., & Rajabzadeh, D. (2006). The impact of health expenditure on the economic growth in IRAN (1980-2004). Journal of health administration, 9(24), 39-44.
Hanvanich, S., & Çavuşgil, S. T. (2001). Stock market reactions to international joint venture announcement: An event analysis. International Business Review, 10(2), 139-154.Cyranoski, D. (2017). China’s genomics giant to make stock-market debut. Nature News, 546(7659), 461- 470
Heidari, H., Kahriz, A. R., & Mohammadzadeh, Y. (2019). Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors. Economic Change and Restructuring, 52(3), 255-277.
Lee, P. M. (1997). A comparative analysis of layoff announcements and stock price reactions in the United States and Japan. Strategic Management Journal, 18(11), 879-894.
Maitra, D., & Dey, K. (2012). Dividend announcement and market response in Indian stock market: An event-study analysis. Global Business Review, 13(2), 269-283.
Mazur, M., Dang, M., & Vega, M. (2021). COVID-19 and the march 2020 stock market crash. Evidence from S&P1500. Finance Research Letters, 38, 101690.
Niroomand, F., Metghalchi, M., & Hajilee, M. (2020). Efficient market hypothesis: a ruinous implication for Portugese stock market. Journal of economics and finance, 44(4), 749-763.
Rossi, M., & Gunardi, A. (2018). Efficient market hypothesis and stock market anomalies: Empirical evidence in four European countries. Journal of Applied Business Research (JABR), 34(1), 183-192.
Thompson, J. (2007). Healthy population is good for the economy. Community Practitioner, 80(1), 39 – 45
Trading Economics (2021) Stock Indexes,https://tradingeconomics.com/
Xiong, H., Wu, Z., Hou, F., & Zhang, J. (2020). Which firm-specific characteristics affect the market reaction of Chinese listed companies to the COVID-19 pandemic?. Emerging Markets Finance and Trade, 56(10), 2231-2242.
Xu, J. (2021). An Empirical Analysis of the Efficient Market Hypothesis in China’s Stock Market. Proceedings of Business and Economic Studies, 4(3), 1-5.
Zhao, J., & Zhou, N. (2021). Impact of human health on economic growth under the constraint of environment pollution. Technological Forecasting and Social Change, 169, 120828.
Published
How to Cite
Issue
Section
License
The author fully assumes the content originality and the holograph signature makes him responsible in case of trial.
